GlobeNewswire

Bombardier Announces Results of its Successful Tender Offers, Elimination of 8.750 Tender Cap and Extension of 8.750% Notes Tender Offer

Share

MONTRÉAL, March 28, 2019 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier” or the “Corporation”) today announced the results of its cash tender offers previously announced on February 28, 2019, as amended on March 14, 2019 (the “Tender Offers”) to purchase for cash up to US$975,000,000 aggregate total consideration payable (including the Early Tender Payment, if applicable) (the “Aggregate Maximum Tender Consideration”) of Bombardier’s 6⅛% Senior Notes due 2021 (CUSIP No. 055320152 / ISIN No. XS0553201525 (144A) / CUSIP No. 055291594 / ISIN No. XS0552915943 (Reg. S)) (the “6⅛% Notes” and the tender offer with respect to the 6⅛% Notes the “6⅛% Notes Tender Offer”) and Bombardier’s 8.750% Senior Notes due 2021 (CUSIP No. 097751BP5 / ISIN No. US097751BP56 (144A) / CUSIP No. C10602BB2 / ISIN No. USC10602BB24 (Reg. S)) (the “8.750% Notes”, together with the 6⅛% Notes, the “Notes”, and the tender offer with respect to the 8.750% Notes the “8.750% Notes Tender Offer”), subject to the terms and conditions of such Tender Offers set forth in the Offer to Purchase (as defined below), subject to amendment as announced hereby.

Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Offer to Purchase dated February 28, 2019 (as amended on March 14, 2019 and as further amended hereby, the “Offer to Purchase”) with respect to the 6⅛% Notes Tender Offer and the 8.750% Notes Tender Offer.

The 6⅛% Notes Tender Offer expired at 11:59 p.m., New York City Time, on March 27, 2019 (such date and time, the “6⅛ % Notes Expiration Date”). The 8.750% Notes Tender Offer was scheduled to expire at 11:59 p.m., New York City Time, on March 27, 2019 (such date and time, the “Original 8.750% Notes Expiration Date”), but is being extended as provided below.

The depositary and information agent under the Tender Offers has advised Bombardier that (i) €12,960,000 aggregate principal amount of the 6⅛% Notes remaining outstanding after the purchase by Bombardier of all 6⅛% Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date have been validly tendered and not validly withdrawn at or prior to the 6⅛% Notes Expiration Date (which amount, together with the €353,055,000 aggregate principal amount of the 6⅛% Notes that was previously tendered under the 6⅛% Notes Tender Offer at or prior to the Early Tender Date and purchased by Bombardier on March 15, 2019, represents, in the aggregate, approximately 46.93% of the aggregate principal amount of the 6⅛% Notes outstanding prior to the Tender Offers) and (ii) US$382,148,000 aggregate principal amount of the 8.750% Notes was validly tendered and not validly withdrawn at or prior to the Original 8.750% Notes Expiration Date (which amount represents approximately 27.30% of the aggregate principal amount of the 8.750% Notes outstanding prior to the Tender Offers).

Bombardier also announced that it is eliminating the 8.750 Tender Cap from the terms and conditions of the 8.750% Notes Tender Offer. The Tender Offers remain subject to the limitation of the Aggregate Maximum Tender Consideration.

Bombardier also announced that it is extending the 8.750% Notes Tender Offer for ten (10) additional business days beyond the Original 8.750% Notes Expiration Date so that the 8.750% Notes Tender Offer will, as a result of this amendment, expire at 11:59 p.m., New York City Time, on April 10, 2019 (the “New 8.750% Notes Expiration Date”). Any 8.750% Notes validly tendered after the Original 8.750% Notes Expiration Date and at or prior to the New 8.750% Expiration Date and not validly withdrawn that are accepted for purchase will receive the Total Consideration, as well as accrued and unpaid interest from the last interest payment date to, but not including, the Further Settlement Date (as defined below).

Bombardier also announced that the settlement date for any 8.750% Notes that have been validly tendered after the Original 8.750% Notes Expiration Date but at or prior to the New 8.750% Notes Expiration Date, not validly withdrawn and accepted for purchase by the Corporation, subject to the Aggregate Maximum Tender Consideration, giving effect to the elimination of the 8.750 Tender Cap as provided hereby and subject to possible proration, will be on a date promptly following the New 8.750% Notes Expiration Date (the “Further Settlement Date”), which date is expected to be the second business day after the New 8.750% Notes Expiration Date.

Bombardier also announced that settlement of all 8.750% Notes that have been validly tendered at or prior to the Original 8.750% Notes Expiration Date, not validly withdrawn and accepted for purchase by the Corporation (giving effect to the elimination of the 8.750 Tender Cap as provided hereby) will occur on the Final Settlement Date, which is expected to be March 29, 2019.

The terms of the 8.750% Notes Tender Offer and the Offer to Purchase are hereby amended to give effect to the above. All other terms of the 8.750% Notes Tender Offer and the Offer to Purchase remain unchanged.

In addition to Bombardier’s early acceptance and purchase of €353,055,000 aggregate principal amount of the 6⅛% Notes as announced on March 14, 2019, Bombardier today accepted for purchase (i) €12,960,000 aggregate principal amount of the 6⅛% Notes, at a purchase price of €1,095 for each €1,000 principal amount of 6⅛% Notes validly tendered after the Early Tender Date but at or prior to the 6⅛% Notes Expiration Date and not withdrawn and accepted for purchase (representing a total aggregate purchase price consideration paid by Bombardier of €14,191,200 under the 6⅛% Notes Tender Offer), and (ii) US$382,148,000 aggregate principal amount of 8.750% Notes at a purchase price of US$1,105 for each US$1,000 principal amount of 8.750% Notes validly tendered at or prior to the Original 8.750% Notes Expiration Date and not withdrawn and accepted for purchase (representing a total aggregate purchase price consideration paid by Bombardier of US$422,273,540 under the 8.750% Notes Tender Offer). In addition, all holders of Notes that have been accepted for purchase in the Tender Offers (other than Notes that were purchased on the Early Settlement Date) will also receive (in addition to the consideration paid for such Notes) accrued and unpaid interest on the Notes from the last interest payment date to, but not including, the Final Settlement Date. Bombardier intends to settle payment for the Notes that have been accepted for purchase (and not purchased on the Early Settlement Date) on March 29, 2019.

Solely for the purposes of determining the aggregate consideration paid for 6⅛% Notes within the Aggregate Maximum Tender Consideration and available for purchases pursuant to the Tender Offers, the aggregate consideration for 6⅛% Notes accepted for purchase pursuant to the 6⅛% Notes Tender Offer was converted into U.S. dollars using the EUR to USD exchange rate as of 2:00 P.M., New York City time on the business day prior to the 6⅛% Notes Expiration Date as reported on Bloomberg screen page “FXIP” under the heading “FX Rate vs. USD,” which was €1.00 equals US$1.1283.

Approximately €413,985,000 aggregate principal amount of 6⅛% Notes will remain outstanding following consummation of the purchase of the 6⅛% Notes accepted under the 6⅛% Notes Tender Offer and settled on the Final Settlement Date, which is expected to be March 29, 2019. As of the Final Settlement Date, approximately US$1,017,852,000 aggregate principal amount of 8.750% Notes will remain outstanding following consummation of the purchase of the Notes accepted under the 8.750% Notes Tender Offer as amended hereby.

None of Bombardier, its subsidiaries or its affiliates, or their respective board of directors, officers or employees, the dealer managers, tender agent and information agent or the trustees for the 8.750% Notes makes any recommendation that Holders tender or refrain from tendering all or any portion of the principal amount of their 8.750% Notes, and no one has been authorized by Bombardier or any of them to make such a recommendation. Holders must make their own decision as to whether to tender their 8.750% Notes, and, if so, the principal amount of 8.750% Notes to tender.

All of the 8.750% Notes are held in book-entry form. If you hold 8.750% Notes through a broker, dealer, bank, trust company or other intermediary or nominee, you must contact such broker, dealer, bank, trust company or other intermediary or nominee if you wish to tender 8.750% Notes pursuant to the 8.750% Notes Tender Offer. You should check with such broker, dealer, bank, trust company or other intermediary or nominee to determine whether they will charge you a fee for tendering 8.750% Notes on your behalf.  You should also confirm with the broker, dealer, bank, trust company or other intermediary or nominee any deadlines by which you must provide your tender instructions, because the relevant deadline set by such nominee will be earlier than the deadlines set forth herein.

For additional information regarding the terms of the Tender Offers, please contact Citigroup Global Markets Inc. at (212) 723-6106 or toll free at (800) 558-3745 or J.P. Morgan Securities LLC at (212) 834-3260 or toll free at (866) 834-4666. Copies of the Offer to Purchase may be obtained at the following http://www.gbsc-usa.com/Bombardier or by contacting Global Bondholder Services Corporation at (866) 470-4200 or by email at contact@gbsc-usa.com.

The Tender Offers are made only by and pursuant to the terms of the Offer to Purchase, as amended in a press release by the Corporation dated March 14, 2019 and as further amended hereby, and the information in this notice is qualified by reference to the Offer to Purchase, subject to the amendments contained in the press release by the Corporation dated March 14, 2019 and herein. None of Corporation, the dealer managers or the information and tender agent make any recommendations as to whether Holders should tender their Notes pursuant to the Tender Offers.

This announcement does not constitute an offer to buy or the solicitation of an offer to sell any securities. The Tender Offers are not being made in any jurisdiction or in any circumstances in which the offers or solicitations contained in the Offer to Purchase are unlawful. In those jurisdictions where the securities, blue sky or other laws require the Tender Offers to be made by a licensed broker or dealer, the Tender Offers will be deemed to be made by the dealer managers or one or more registered brokers or dealers licensed under the laws of such jurisdiction.

Certain statements in this announcement are forward-looking statements based on current expectations. By their nature, forward‑looking statements require us to make assumptions and are subject to important known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from those set forth in the forward-looking statements. For additional information regarding these risks and uncertainties, and the assumptions underlying the forward‑looking statements, please refer to the Offer to Purchase.

For information

Simon Letendre
Manager, Media Relations and Public Affairs
Bombardier Inc.
+514 924 4893
Patrick Ghoche
Vice President, Investor Relations
Bombardier Inc.
+514 861 5727

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

ClarionDoor Adds New Head of Data and Analytics16.7.2019 11:00:00 CESTPress release

Increasing efficiency of data-intensive processes creates deeper need for data scientists by insurers. SANTA BARBARA, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- The explosion of Big Data in the last five to ten years has hit the insurance industry hard due to the inability of legacy technology systems to effectively capture, store, integrate, and utilize unstructured data, in particular, and created an urgent need for data scientists. Forward-thinking insurance industry solution providers, like ClarionDoor, Inc. (ClarionDoor) , developer of enterprise-class, cloud-based rating, quoting, and issuance solutions for property and casualty (P&C) insurers, are adding bench strength with significant data mastery capabilities to help offset the gap for insurance company clients. Notably, ClarionDoor recently added Mark Heslop to the leadership team as the company’s new Head of Data and Analytics. “Mark is an important addition to our team,” said Michael DeGusta, CEO of ClarionDoor. “He will be

Epistem licence Hubrecht Organoid Technology to expand pre-clinical toxicology service portfolio16.7.2019 10:52:00 CESTPress release

MANCHESTER, United Kingdom, July 16, 2019 (GLOBE NEWSWIRE) -- Epistem Limited, the UK based pre-clinical and clinical research services company announces the expansion of its in vitro model portfolio by the completion of an agreement with Hubrecht Organoid Technology (HUB) to enable the delivery of an increased range of multi species organoid models. Services are focused on the identification of off target or off tissue intestinal toxicities associated with various therapeutics. Specifically, Epistem aims to help customers define whether there are reasons to suspect that there may be human toxicity issues. This will allow better prioritisation of lead compounds, with customers able to make early decisions on whether to abandon, identify alternatives, or develop mitigation strategies for any drugs with human toxicity. Organoids are adult stem cell patient or animal derived structures. Organoids are genetically stable and maintain epithelial functionality in the laboratory. The expanding

Bombardier’s Multi-Award-Winning Global 7500 Jet Reaches New Heights in the Heart of the Swiss Alps15.7.2019 19:00:00 CESTPress release

Global 7500 aircraft is the most spacious purpose-built business jet to operate out of Gstaad’s Saanen airport in Switzerland, where it was on display earlier this month before flying to Dubai, performing another exceptional long-range mission Mission highlights the Global family’s advanced wing design, which enables them to access challenging airfields with short runways in hot temperatures and/or high altitude locations, giving passengers direct access to the heart of the Swiss Alps all year round The Aviation Week Grand Laureate Global 7500 aircraft, also recently recognized as Business Jet of the Year in Robb Report’s Best of the Best 2019, offers Bombardier’s signature smooth ride and a spaciousness that is unique among business jets Bombardier’s Challenger 350 aircraft, also recognized as the Best of the Best Super Mid-size Aircraft by Robb Report, joined the Global 7500 jet on display in Gstaad and achieved a speed record, reaching Malaga in 2 hours and 4 minutes MONTREAL, July

Brookfield Asset Management 2019 Second Quarter Results Conference Call and Webcast15.7.2019 18:27:00 CESTPress release

Date: Thursday, August 8, 2019 Time: 11:00 a.m. (Eastern Time) BROOKFIELD, NEWS, July 15, 2019 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE:BAM)(TSX:BAM.A)(EURONEXT AMSTERDAM:BAMA): Second Quarter Conference Call You are invited to participate in Brookfield Asset Management’s 2019 Second Quarter Conference Call & Webcast on Thursday, August 8, 2019 at 11:00 a.m. (Eastern Time) to discuss with members of senior management our results and current business initiatives. These results will be released on August 8th before 7:00 a.m. (Eastern Time) and will be available following the release on our website at www.brookfield.com “News – Press Releases.” The Conference Call will also be Webcast live on our website, where it will be archived for future reference. To participate in the Conference Call, please dial 1-866-688-9425 toll free in North America, or for overseas calls please dial 1-409-216-0815 (Conference ID: 8258617) at approximately 10:50 a.m. The Conference Call will also b

Virtusa Achieves AWS Life Sciences Competency Status15.7.2019 16:01:00 CESTPress release

Virtusa joins a group of AWS Partner Network members helping Life Sciences providers to deliver superior patient outcomes SOUTHBOROUGH, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for its clients, announced today that it has achieved Amazon Web Services (AWS) Life Sciences Competency status. This designation recognizes Virtusa for providing deep expertise in building Life Sciences solutions on AWS to help customers conduct drug discovery, manage clinical trials, engage in manufacturing and distribution activities, conduct research and development of novel genetic-based treatments and companion diagnostics. Achieving the AWS Life Sciences Competency differentiates Virtusa as an AWS Partner Network (APN) member that has demonstrated relevant technical proficiency and proven customer success, delivering solutions seamlessly on AWS.

LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec15.7.2019 15:28:00 CESTPress release

MONTREAL, July 15, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) LGC Capital Ltd. (“LGC” or the “Company”), announces that Health Canada, on July 12th, awarded Trichomed Corporation (Trichomed), its long awaited license to cultivate cannabis seeds and plants at its newly constructed facility in Brownsburg, Quebec. As per the terms of its agreement with Trichomed, LGC is, now entitled to convert the first ranking secured loan it provided to Trichomed in December 2017 into a 49% direct equity interest, and a five percent (5%) royalty of Trichomed’s net sales of cannabis and cannabis-related prodcuts which covers actual sales less any arm’s length third-party discounts, merchandise returns and rebates. In addition as per the agreement, LGC is entitled to representation on Trichomed’s board. For further information, please contact: John McMullen, President Tel: (416) 803-0698 john@lgc-capital.com Mark Shinners, Chief Financial Officer Tel: +44 7827 960971 mark@lgc-ca